-
公开(公告)号:US5304571A
公开(公告)日:1994-04-19
申请号:US910467
申请日:1992-07-08
申请人: Douglas G. Johnson , Allan E. Titus
发明人: Douglas G. Johnson , Allan E. Titus
CPC分类号: A61K47/02 , A61K31/34 , A61K47/26 , A61K9/0019
摘要: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H.sub.2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.
摘要翻译: 提供了一种药物组合物,其包含含有有效量的雷尼替丁的无缓冲等渗水性制剂,用于治疗通过组胺H 2受体介导的病症。 制剂具有大于或等于5.0且小于6.5的pH,并且优选包括选自右旋糖和氯化钠的渗透调节剂。
-
公开(公告)号:US5169864A
公开(公告)日:1992-12-08
申请号:US793043
申请日:1991-11-15
申请人: Douglas G. Johnson , Allan E. Titus
发明人: Douglas G. Johnson , Allan E. Titus
CPC分类号: A61K47/02 , A61K31/34 , A61K47/26 , A61K9/0019
摘要: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H.sub.2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.
摘要翻译: 提供了一种药物组合物,其包含含有有效量的雷尼替丁的无缓冲等渗水性制剂,用于治疗通过组胺H 2受体介导的病症。 制剂具有大于或等于5.0且小于6.5的pH,并且优选包括选自右旋糖和氯化钠的渗透调节剂。
-
公开(公告)号:US5650421A
公开(公告)日:1997-07-22
申请号:US414433
申请日:1995-03-31
申请人: Allan E. Titus , Douglas G. Johnson
发明人: Allan E. Titus , Douglas G. Johnson
IPC分类号: A61K31/426 , A61K31/425
CPC分类号: A61K31/426
摘要: A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4.5 to about 8.0, and a shelf life greater than 30 days.
摘要翻译: 一种药物组合物,其包含具有有效量的法莫替丁的溶液,所述溶液的pH在约4.5至约8.0的范围内,保质期大于30天。
-
-